TGFB1 and familial pancreatic carcinoma: The immunosuppressive effects of TGF-β enabling cancer progression and development of TGF-β inhibitors as antitumor agents have been discussed in the context of various cancers such as liver, cervical, breast, colon, lung, prostate, esophageal, and pancreatic cancer (23, 24).